| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
15,080,000 |
| Market
Cap: |
50.52(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.06 - $6.77 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cumberland Pharmaceuticals is a pharmaceutical company engaged on the acquisition, development and commercialization of prescription products. Co.'s portfolio of brands include: Acetadote® (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor® (ibuprofen) injection, for the treatment of pain and fever; Kristalose® (lactulose) for the treatment of constipation; Omeclamox®-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori infection and related duodenal ulcer disease; and Vaprisol® (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
2,930 |
4,150 |
32,918 |
32,918 |
| Total Buy Value |
$13,963 |
$20,376 |
$58,763 |
$58,763 |
| Total People Bought |
4 |
4 |
4 |
4 |
| Total Buy Transactions |
172 |
252 |
484 |
484 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kazimi A J |
Chairman and CEO |
• • • |
2025-05-30 |
4 |
AB |
$4.93 |
$39 |
D/D |
8 |
5,699,260 |
|
-48% |
|
| Young Caroline |
Director |
– • – |
2025-05-30 |
4 |
AB |
$4.93 |
$20 |
D/D |
4 |
32,569 |
|
-48% |
|
| Jones James |
Director |
– • – |
2025-05-30 |
4 |
AB |
$4.93 |
$39 |
D/D |
8 |
43,168 |
|
-48% |
|
| Krogulski Kenneth |
Director |
– • – |
2025-05-30 |
4 |
AB |
$4.93 |
$222 |
D/D |
45 |
285,698 |
|
-48% |
|
| Kazimi A J |
Chairman and CEO |
• • • |
2025-05-29 |
4 |
AB |
$5.66 |
$45 |
D/D |
8 |
5,699,252 |
|
-48% |
|
| Young Caroline |
Director |
– • – |
2025-05-29 |
4 |
AB |
$5.66 |
$23 |
D/D |
4 |
32,565 |
|
-48% |
|
| Jones James |
Director |
– • – |
2025-05-29 |
4 |
AB |
$5.66 |
$45 |
D/D |
8 |
43,160 |
|
-48% |
|
| Krogulski Kenneth |
Director |
– • – |
2025-05-29 |
4 |
AB |
$5.66 |
$255 |
D/D |
45 |
285,653 |
|
-48% |
|
| Kazimi A J |
Chairman and CEO |
• • • |
2025-05-28 |
4 |
AB |
$5.68 |
$45 |
D/D |
8 |
5,699,244 |
|
-55% |
|
| Young Caroline |
Director |
– • – |
2025-05-28 |
4 |
AB |
$5.68 |
$23 |
D/D |
4 |
32,561 |
|
-55% |
|
| Jones James |
Director |
– • – |
2025-05-28 |
4 |
AB |
$5.68 |
$45 |
D/D |
8 |
43,152 |
|
-55% |
|
| Krogulski Kenneth |
Director |
– • – |
2025-05-28 |
4 |
AB |
$5.68 |
$256 |
D/D |
45 |
285,608 |
|
-55% |
|
| Kazimi A J |
Chairman and CEO |
• • • |
2025-05-27 |
4 |
AB |
$5.27 |
$42 |
D/D |
8 |
5,699,236 |
|
-51% |
|
| Young Caroline |
Director |
– • – |
2025-05-27 |
4 |
AB |
$5.27 |
$21 |
D/D |
4 |
32,557 |
|
-51% |
|
| Jones James |
Director |
– • – |
2025-05-27 |
4 |
AB |
$5.27 |
$42 |
D/D |
8 |
43,144 |
|
-51% |
|
| Krogulski Kenneth |
Director |
– • – |
2025-05-27 |
4 |
AB |
$5.27 |
$237 |
D/D |
45 |
285,563 |
|
-51% |
|
| Kazimi A J |
Chairman and CEO |
• • • |
2025-05-23 |
4 |
AB |
$5.14 |
$41 |
D/D |
8 |
5,699,228 |
|
-49% |
|
| Young Caroline |
Director |
– • – |
2025-05-23 |
4 |
AB |
$5.14 |
$21 |
D/D |
4 |
32,553 |
|
-49% |
|
| Jones James |
Director |
– • – |
2025-05-23 |
4 |
AB |
$5.14 |
$41 |
D/D |
8 |
43,136 |
|
-49% |
|
| Krogulski Kenneth |
Director |
– • – |
2025-05-23 |
4 |
AB |
$5.14 |
$231 |
D/D |
45 |
285,518 |
|
-49% |
|
| Kazimi A J |
Chairman and CEO |
• • • |
2025-05-22 |
4 |
AB |
$5.10 |
$41 |
D/D |
8 |
5,699,220 |
|
-49% |
|
| Young Caroline |
Director |
– • – |
2025-05-22 |
4 |
AB |
$5.10 |
$20 |
D/D |
4 |
32,549 |
|
-49% |
|
| Jones James |
Director |
– • – |
2025-05-22 |
4 |
AB |
$5.10 |
$41 |
D/D |
8 |
43,128 |
|
-49% |
|
| Krogulski Kenneth |
Director |
– • – |
2025-05-22 |
4 |
AB |
$5.10 |
$230 |
D/D |
45 |
285,473 |
|
-49% |
|
| Kazimi A J |
Chairman and CEO |
• • • |
2025-05-21 |
4 |
AB |
$5.05 |
$40 |
D/D |
8 |
5,699,212 |
|
-48% |
|
3152 Records found
|
|
Page 1 of 127 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.75 (28.85%) 
